Skip to content

Abivax

  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • Overview
    • ABX464 for UC
    • ABX464 for HIV
    • ABX196 for HCC
    • ABX544 for Ebola Virus
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Overview
    • Share Price
    • Investor Documents
    • Annual General Meeting
    • UEG Week 2019
  • Contact Us
Search
  • EN
  • FR
  • DE

Investors

Investor Documents

  • Number of Shares and Vote Rights - November 2018

    December 18, 2018
  • Number of Shares and Vote Rights - October 2018

    November 16, 2018
  • Number of Shares and Vote Rights - September 2018

    October 16, 2018
  • 2018 Half-Year Financial Report

    September 28, 2018
  • First-Half 2018 Financial Results and Operations Update

    September 28, 2018
  • Number of Shares and Vote Rights - August 2018

    September 26, 2018
  • Number of Shares and Vote Rights - July 2018

    August 31, 2018
  • Half-Year Report for Liquidity Contract - June 30, 2018

    July 20, 2018
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10

Investor Contact

Chris Maggos LifeSci Advisors Chris@lifesciadvisors.com +41 79 367 6254
© 2019 All rights reserved by ABIVAX Privacy and Terms of Use
  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • ABX464 for UC
    • ABX464 for HIV
    • ABX196 for HCC
    • ABX544 for Ebola Virus
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Share Profile
    • Share Price
    • Investor Documents
    • Analysts
    • Annual General Meeting
    • UEG Week 2019
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn
  • Follow us on YouTube
  • Follow us on Google+